Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of R89674 0.25% Ophthalmic Solution in Healthy, Normal Volunteers

NCT00223951 is registered in ClinicalTrials.gov with Vistakon Pharmaceuticals as lead sponsor.

NCT NCT00223951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00223951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of R89674 0.25% Ophthalmic Solution in Healthy, Normal Volunteers
Lead sponsor
Vistakon Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2005
Completion date
Not reported
Enrollment
900
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers eligible for study; drug being developed for allergic conjunctivitis